Press Release November 10, 2021Merck and Ridgeback Announce Japanese Government to Purchase 1.6 Million Courses of Molnupiravir, an Investigational Oral COVID-19 Antiviral Medicine, Upon Authorization or Approval 0 0 Share
Company Ticker News November 10, 2021Merck and Ridgeback Biotherapeutics say Japan to purchase 1.6 million courses of their COVID antiviral if it's authorized 0 0 Share
Company Ticker News November 9, 2021US Government To Purchase Additional 1.4M Doses Of Merck's COVID-19 Pill 0 0 Share
Company Ticker News November 9, 2021U.S. Inks $1 Billion Deal For Extra Doses Of Merck's Antiviral Covid Pill 0 0 Share
Company Ticker News November 8, 2021Merck Announces Receipt of Antitrust Clearance in Germany and Austria Relating to Tender Offer to Acquire Acceleron Pharma Inc. 0 0 Share
Company Ticker News November 6, 20212 Health Care Stocks to Consider on Covid-19 Treatment Updates 0 0 Share
Company Ticker News November 6, 2021Dow Jones Gains 300 Points on Jobs Report, Merck Shares Slammed on Pfizer's COVID Pill Results 0 0 Share
